suramin has been researched along with estramustine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (63.64) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Pienta, KJ; Redman, BG | 1 |
Panvichian, R; Pienta, KJ | 1 |
Abi-Rashid, B; Petrylak, DP | 1 |
Smith, DC | 1 |
Arah, IN; Dixon, SC; Figg, WD; Horti, J | 1 |
Beedassy, A; Cardi, G | 1 |
Roth, BJ | 1 |
Heidenreich, A; Hofmann, R; von Knobloch, R | 1 |
Knox, JJ; Moore, MJ | 1 |
Heicappell, R | 1 |
9 review(s) available for suramin and estramustine
Article | Year |
---|---|
New treatment strategies for hormone refractory prostate cancer.
Topics: Estramustine; Etoposide; Humans; Male; Prostatic Neoplasms; Suramin; Vinblastine | 1995 |
The treatment of hormone refractory prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prognosis; Prostatic Neoplasms; Suramin; Vinblastine | 1996 |
Therapy for hormone-resistant prostate cancer: no longer a myth.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Estramustine; Humans; Ketoconazole; Male; Prostatic Neoplasms; Suramin; Treatment Outcome | 1996 |
Chemotherapy for hormone refractory prostate cancer.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cyclophosphamide; Estramustine; Humans; Male; Prostatic Neoplasms; Suramin | 1999 |
Chemotherapy in advanced prostate cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Doxorubicin; Estramustine; Humans; Liposomes; Male; Mitoxantrone; Neoplasms, Hormone-Dependent; Palliative Care; Prostatic Neoplasms; Suramin | 1999 |
Androgen-independent prostate cancer: not so chemorefractory after all.
Topics: Antineoplastic Combined Chemotherapy Protocols; Estramustine; Humans; Male; Mitoxantrone; Prostatic Neoplasms; Suramin | 1999 |
Current status of cytotoxic chemotherapy in hormone refractory prostate cancer.
Topics: Anthracyclines; Antineoplastic Agents; Estramustine; Humans; Male; Prognosis; Prostatic Neoplasms; Risk Factors; Suramin | 2001 |
Treatment of hormone refractory prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Humans; Male; Mitoxantrone; Pain; Palliative Care; Prednisone; Prostatic Neoplasms; Quality of Life; Suramin | 2001 |
Controversies in chemotherapy of prostate cancer.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgen Antagonists; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clinical Trials as Topic; Docetaxel; Estramustine; Humans; Male; Mitoxantrone; Neoplasms, Hormone-Dependent; Paclitaxel; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Suramin; Taxoids; Testosterone; Treatment Outcome | 2002 |
2 other study(ies) available for suramin and estramustine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Estramustine; Etoposide; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured; Vinblastine | 1999 |